ArticleScientific reports2024

Development of chimeric MrNV virus-like particles capable of binding to SARS-CoV-2-susceptible cells and reducing infection by pseudovirus variants.

Supawich Boonkua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.